31 08, 2020

IN PRESS: Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis

By |2020-08-31T10:47:49-07:00August 31st, 2020|Articles in Press|0 Comments

Mehak Pahwa, MD; Nicolas A Nuñez, MD; Boney Joseph, MBBS; Ashok Seshadri; Danielle J. Gerberi; Mark A Frye AND Balwinder Singh ABSTRACT Background: Patients with Borderline Personality Disorder (BPD) have a high prevalence of mood disorders. Lamotrigine (LAM) is often used as an off-label therapeutic option for BPD. We aimed [...]

31 08, 2020

IN PRESS: The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports

By |2020-08-31T09:33:37-07:00August 31st, 2020|Articles in Press|0 Comments

By Arpit Aggarwal and Victoria Lindegaard ABSTRACT ~ Nightmares are psychologically distressing events that may cause significant effects on mental health, physical well-being and overall quality of life, in addition to their negative impact on quality and duration of sleep. Drug dreams are a variant of nightmares and a known [...]

31 08, 2020

IN PRESS: Lumateperone for the Treatment of Schizophrenia

By |2020-08-31T09:27:39-07:00August 31st, 2020|Articles in Press|0 Comments

By Amber Edinoff, MD; Natalie Wu, MD; Charles deBoisblanc; Catherine Olivia Feltner;  Mariah Norder; Vesela Tzoneva, MD; Adam M. Kaye; Elyse M. Cornett; Alan D. Kaye; Omar Viswanath; and Ivan Urits Abstract  Introduction Schizophrenia is a severe psychotic disorder that is diagnosed by the presence of hallucinations or delusions along [...]

30 08, 2020

IN PRESS: An Update On The Efficacy And Tolerability Of Oral Ketamine For Major Depression: A Systematic Review And Meta-Analysis

By |2020-08-30T10:00:12-07:00August 30th, 2020|Articles in Press|0 Comments

Nicolas A Nuñez, MD, MS, Boney Joseph, MBBS, , Mehak Pahwa, MD, Ashok Seshadri, MD, Larry Prokop, MLS, Simon Kung, MD, Kate Schack, MD, Jennifer VandeVoort, MD, Mark A Frye, MD, Balwinder Singh MD, MS ABSTRACT Background: Intravenous Ketamine has shown robust antidepressant efficacy although other routes of administration are [...]

30 08, 2020

IN PRESS: Asenapine Transdermal Patch for the Management of Schizophrenia

By |2020-08-30T10:00:35-07:00August 30th, 2020|Articles in Press|0 Comments

By Maxine Zhou, Sahar Derakhshanian, Alexander Rath, Sarah Bertrand, Caroline DeGraw, Rachel Barlow, Aja Menard, Adam M. Kaye, Jamal Hasoon, Elyse M. Cornett, Alan D. Kaye, Omar Viswanath, Ivan Urits ABSTRACT ~ Purpose of Review: This is a comprehensive review of the literature regarding the use of asenapine for the [...]